explore -WSS

explore

author：entertainment 2025-09-30 00:49:04 - browse：73374

Eric Lander White House science office — Eric Lander resigned as President Biden’s science adviser, after a White House investigation found “credible evidence” that he had violated workplace conduct rules. Photo illustration: Alex Hogan/STAT; Source: Getty

WASHINGTON — An early sign that trouble was afoot in the White House science office came last November, when roughly a dozen of Eric Lander’s staff formed a “culture committee” aimed at improving morale.

The group’s first action, five aides told STAT, was to create a “word cloud” depicting the adjectives they most often used to describe the work environment at the White House Office of Science and Technology Policy. Of the dozens of words submitted, three in particular stood out: “hostile,” “siloed,” and “aggressive.”

Three months later, Lander resigned as President Biden’s science adviser, after Politico reported a White House investigation that found “credible evidence” that he had violated workplace conduct rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： J&J lung cancer data amount to new salvo against AstraZeneca

hotspot

focus

WSS

What drug price negotiations mean for Medicare Part D

Crinetics acromegaly drug succeeds in late

Trump surgeon general acknowledges mistakes during Covid

Snackable artificial intelligence, expert AI, and the pharma industry

'Make People Better': The CRISPR babies story you probably don't know

Listen: Biogen's potential pivot, & Illumina's next chapter

hotspot

explore

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Summit: Meghan O’Rourke on making chronic illness visible

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Listen: Biogen's potential pivot, & Illumina's next chapter

The high cost of giving birth even with insurance

Stem cell treatment guidelines are released by FDA

23andMe had bad news about my health. I wish a person had delivered it

The (many) problems with a new study criticizing cancer screening

At least 13 dead in Texas as scorching temps continue

A new House health package & hospitals’ new site

explore

STAT Readout Newsletter: Biotech news today

Weighted lottery helped low

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Listen: Biogen's potential pivot, & Illumina's next chapter

Is there really a nursing shortage in the U.S.?

Medicaid rebukes states for mistakenly disenrolling children

hotspot

knowledge

focus

leisure time